Clinical Trial Update: Bexarotene With Narrow-Band UVB for Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bexarotene in combination with narrow-band UVB for psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Bexarotene with Narrow-Band UVB (bexarotene)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Psoriasis | Phase 2 | Status: COMPLETED